Hagopian Henry III
SEC CIK 1821822 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANVS | Annovis Bio, Inc. | CFO | 1,820 | — | — | 3 | 2023-04-07 | 2023-11-20 |
Most active insiders at ANVS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hoffman Michael B | Dir | $4.26M | — |
| 2 | Maccecchini Maria-Luisa | Pres, CEO, Dir | $200.0K | — |
Hagopian Henry III made no open-market trades at ANVS in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-11-22 | 2023-11-20 | ANVS | Annovis Bio, Inc. | Hagopian Henry III | CFO | A - Grant | $6.10 | +820 | 1,820 | +82% | +$5,002 |
| 2023-11-21 | 2023-11-20 | ANVS | Annovis Bio, Inc. | Hagopian Henry III | CFO | A - Grant | $6.07 | +824 | 1,824 | +82% | +$5,002 | |
| 2023-04-11 | 2023-04-07 | ANVS | Annovis Bio, Inc. | Hagopian Henry III | CFO | A - Grant | $12.61 | +1,000 | 1,000 | New | +$12.6K |
Purchase Sale Sale after option exercise All abbreviations